Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kegan Wellness appears to be an India-based nutraceutical and consumer health company focused on women's wellness supplements and related dietary products. Publicly available marketplace and profile pages describe the business as marketing vitamins, nutraceuticals, and female wellness products, including branded supplements such as She+ and Giloe+ and other wellness offerings. The company was also the recipient of a July 13, 2020 FDA/FTC warning letter concerning unapproved and misbranded COVID-19-related claims made for certain products sold into the United States. Available evidence suggests Kegan Wellness operated primarily as a commercial supplement marketer and distributor rather than a drug-development biotech with a disclosed therapeutic pipeline. Current evidence for an active standalone operating presence is weak, and some business-registration data indicate the GST trade status was later cancelled.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kegan Wellness.